Filing Details
- Accession Number:
- 0000049071-20-000144
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-11-06 13:13:05
- Reporting Period:
- 2020-11-04
- Accepted Time:
- 2020-11-06 13:13:05
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
49071 | Humana Inc | HUM | Hospital & Medical Service Plans (6324) | 610647538 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1699799 | Alan Timothy Wheatley | Humana Inc. 500 West Main Street Louisville KY 40202 | Segment President, Retail | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Humana Common | Acquisiton | 2020-11-04 | 10,914 | $217.42 | 18,803 | No | 4 | M | Direct | |
Humana Common | Acquisiton | 2020-11-04 | 2,207 | $268.47 | 21,010 | No | 4 | M | Direct | |
Humana Common | Disposition | 2020-11-04 | 13,121 | $446.43 | 7,889 | No | 4 | S | Direct | |
Humana Common | Disposition | 2020-11-04 | 2,138 | $449.48 | 5,751 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Humana Common | Options | Disposition | 2020-11-04 | 10,914 | $0.00 | 10,914 | $217.42 |
Humana Common | Options | Disposition | 2020-11-04 | 2,207 | $0.00 | 2,207 | $268.47 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
918 | 2024-03-08 | No | 4 | M | Direct | |
2,209 | 2025-02-19 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Humana Common | 911 | Indirect | See Footnote |
Reported Derivative Holdings
Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|---|---|---|---|
Humana Common | Options | $271.14 | 2025-03-01 | 928 | 928 | Direct | |
Humana Common | Options | $307.97 | 2026-02-25 | 7,902 | 7,902 | Direct | |
Humana Common | Options | $350.79 | 2027-02-24 | 8,595 | 8,595 | Direct | |
Humana Common | Restricted Stock Units | $0.00 | 513 | 513 | Direct | ||
Humana Common | Restricted Stock Units | $0.00 | 108 | 108 | Direct | ||
Humana Common | Restricted Stock Units | $0.00 | 1,191 | 1,191 | Direct | ||
Humana Common | Restricted Stock Units | $0.00 | 1,710 | 1,710 | Direct | ||
Humana Common | Phantom Stock Units | $0.00 | 138 | 138 | Indirect |
Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|
2025-03-01 | 928 | 928 | Direct |
2026-02-25 | 7,902 | 7,902 | Direct |
2027-02-24 | 8,595 | 8,595 | Direct |
513 | 513 | Direct | |
108 | 108 | Direct | |
1,191 | 1,191 | Direct | |
1,710 | 1,710 | Direct | |
138 | 138 | Indirect |
Footnotes
- Shares held for the benefit of reporting person as of October 31, 2020 under the Humana Retirement Savings Plan including routine payroll deductions, quarterly dividend allocation, and a routine disposition of shares to fund an administrative fee assessment under a Tax-Conditioned Plan, exempt under Rule 16b-3(c).
- Right to buy pursuant to Company's 2011 Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 03/08/2017. 12,998 options vesting in three annual increments, and 7,499 options fully vest three years from the date of grant.
- Right to buy pursuant to Company's 2011 Stock Incentive Plan. Non-Qualified stock options granted to reporting person on 02/19/2018, vesting in three increments from 02/19/2019 to 02/19/2021.
- Right to buy pursuant to Company's 2011 Stock Incentive Plan. Non-Qualified stock options granted to reporting person on 02/25/2019, vesting in three increments from 2/25/20 to 2/25/22.
- Right to buy pursuant to Company's 2011 Stock Incentive Plan. Non-Qualified stock options granted to reporting person on 03/1/2018, vesting in three increments from 3/1/19 to 3/1/21.
- Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/24/2020, vesting in three annual increments from 2/24/21 to 2/24/23.
- Right to receive one share per restricted stock unit pursuant to the Company's 2011 Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).
- Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).
- Restricted stock units granted to reporting person on 02/19/18, 33% of the award is vesting on 12/15/18, 12/15/19 and 12/15/20.
- Restricted stock units granted to reporting person on 03/1/18, 33% of the award is vesting on 12/15/18, 12/15/19 and 12/15/20.
- Restricted stock units granted to reporting person on 02/25/19, 33% of the award is vesting on 12/15/19, 12/15/20 and 12/15/21.
- Restricted stock units granted to reporting person on 02/24/2020, 33% of the award is vesting on 12/15/20, 12/15/21, and 12/15/22.
- Phantom Stock Units held for the benefit of reporting person as of October 31, 2020 based on the value of Humana common stock on a 1-for-1 basis, under the Humana Retirement Equalization Plan. The ending number of units reflects normal fluctuation due to changes in stock price.
- Shares sold at prices ranging from $445.09 to $448.11. Price reported is weighted average sales price.
- All shares sold at reported price.